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        All mature blood cells arise from primitive pro-
genitor cells in the BM. These rare and special-
ized cells, called hematopoietic stem cells (HSCs), 
exist mostly in a quiescent state (  1  ). Cell division 
of HSCs results in both their progressive prolifer-
ation and diff  erentiation into increasingly lineage-
restricted mature blood cells, as well as maintenance 
of a small pool of HSCs that do not diff  erentiate, 
but rather carry out hematopoiesis throughout 
the life of an organism (  2  ). Much work has been 
done to elucidate the nature of the signals that 
govern the balance between self-renewal and dif-
ferentiation of HSCs. The BM microenviron-
ment in which these cells reside, called the HSC 
niche, is thought to nurture this balance by pro-
viding the appropriate signals (  3, 4  ), but the iden-
tities and precise coordination of these signals 
have only recently begun to be understood. 
  As the entire life of an HSC revolves around 
the decisions of whether or not and when to 
divide, it is no surprise that several molecules 
and signaling pathways that could regulate cell 
cycle have been implicated in HSC biology 
(  5  –  10  ). For example, the proto-oncogene c-
Myc has been shown to be essential for regulat-
ing both HSC self-renewal and diff  erentiation 
(  11  ). The eff  ects of c-Myc deletion in the BM 
are alleviated by simultaneous deletion of the 
cell cycle inhibitor p21 (  12  ), underscoring the 
requirement for strict cell cycle regulation to 
ensure proper HSC function. Both p21 and c-
Myc are regulated at the transcriptional level 
by the Rho GTPase Cdc42, and deletion of 
Cdc42 from hematopoietic cells results in in-
creased and decreased levels of c-Myc and p21, 
respectively, and allows quiescent HSCs to en-
ter the cell cycle and diff  erentiate (  13  ). 
  In addition to c-Myc, the Notch pathway has 
also been suggested to infl  uence HSC function. 
Notch1 signaling is essential during hemato-
poiesis for the development of T lymphocytes 
(  14, 15  ), but studies of its role in HSCs have 
yielded a mixture of results and interpretations. For 
example, inhibition of Notch1 signaling in vivo 
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  Ubiquitination is a posttranslational mechanism that controls diverse cellular processes. We 
focus here on the ubiquitin ligase Fbw7, a recently identifi  ed hematopoietic tumor suppres-
sor that can target for degradation several important oncogenes, including Notch1, c-Myc, 
and cyclin E. We have generated conditional Fbw7 knockout animals and inactivated the 
gene in hematopoietic stem cells (HSCs), progenitors, and their differentiated progeny. 
Deletion of Fbw7 specifi  cally and rapidly affects hematopoiesis in a cell-autonomous 
manner. Fbw7      /      HSCs show defective maintenance of quiescence, leading to impaired 
self-renewal and a severe loss of competitive repopulating capacity. Furthermore, Fbw7      /      
progenitors are unable to colonize the thymus, leading to a profound depletion of T cell 
progenitors. Deletion of Fbw7 in bone marrow (BM) stem cells and progenitors leads to the 
stabilization of c-Myc, a transcription factor previously implicated in HSC self-renewal. On 
the other hand, neither Notch1 nor cyclin E is visibly stabilized in the BM of Fbw7-defi  -
cient mice. Gene expression studies of Fbw7      /      HSCs and hematopoietic progenitors indi-
cate that Fbw7 regulates, through the regulation of HSC cycle entry, the transcriptional 
  “  signature  ”   that is associated with the quiescent, self-renewing HSC phenotype. 1396 HSC REGULATION BY FBW7 | Thompson et al.
lineage        Sca-1  +  c-Kit  +   (LSK) fraction as well as more diff  eren-
tiated myeloid progenitors (MPs; lineage        Sca-1        c-Kit  +  ), B 
cell progenitors (B220  +  CD43  +  ), and thymic T cell (lineage       
CD44  +  25  +  ) progenitors. As shown in Fig. S1 A (available at 
http://www.jem.org/cgi/content/full/jem.20080277/DC1), 
Fbw7 mRNA expression was high at the LSK stage and de-
creased as the cells diff  erentiated into the myeloid lineage 
(MP: lineage        c-kit  +  Sca-1        ). B cell progenitors expressed 
moderate amounts of Fbw7 message, whereas in the thymus, 
the fi  rst T cell  –  committed progenitors (CD44  +  25  +  ) expressed 
high amounts of Fbw7. There was no signifi  cant expression 
diff  erence during CD4        8         to CD4  +  8  +   transition. However, 
single positive (CD4 or CD8) T cells appear to express lower 
levels of Fbw7 message (Fig. S1 B). The levels of Cullin 1, 
a partner of Fbw7 for the formation of the SCF complex, 
follow similar  —  although not identical  —  expression patterns. 
Finally, to gain further insight in the putative function of 
Fbw7 during early hematopoiesis, we have generated PCR 
primers specifi  c for the three distinct Fbw7 isoforms. We 
were surprised to see that mouse hematopoietic cells express 
only the Fbw7      isoform that is exclusively localized in the 
cell nucleoplasm (Fig. S1 C). These studies suggested a dy-
namic control of Fbw7 expression at diff  erent stages of hema-
topoietic diff  erentiation. 
  Generation of a conditional Fbw7 allele (Fbw7  f/f  ) 
  As the early lethality of the Fbw7       /       embryos precludes any 
study of hematopoietic diff  erentiation, we generated an Fbw7-
conditional allele targeting exons 5 and 6, as they encode for 
the F-box domain that is essential for SCF assembly (  Fig. 1 A  ).   
We have used standard embryonic stem (ES) cell  –  targeting 
techniques and   “  fl  oxed  ”   these two exons with LoxP sites. We 
have also inserted an Frt-  “  fl  oxed  ”   Neo mini-gene that was 
later deleted (  Fig. 1 B  ) from the germline of the generated 
chimeric progeny (see Materials and methods). Fbw7  f/f     (NEO     )   
mice were crossed to the IFN-      (and polyI-polyC)  –  inducible 
Mx1-cre transgenic mouse stain (  33  ) to generate a model of 
inducible Fbw7 deletion (Mx-cre  +   Fbw7  f/f  ). As shown in 
  Fig. 1 (B and C)  , three polyI-polyC intraperitoneal injections 
are suffi   cient to induce total Fbw7 locus deletion and effi   -
ciently silence Fbw7 expression in several lymphoid tissues, 
including the BM, the thymus, and the spleen. The deletion 
was also total in the BM LSK fraction (see   Fig. 8  ). 
  Deletion of Fbw7 severely affects hematopoietic progenitor 
maintenance in the BM 
  We focused our initial analysis on the early stages of BM he-
matopoiesis. As early as 2 wk after the end of the polyI-polyC 
treatment, there was a signifi  cant reduction in the absolute 
number of total BM cells (  Fig. 2 A  ).   We should note here 
that control littermates were either Mx-cre  +   Fbw7  wt/wt   or 
Mx-cre         Fbw7  f/f   mice and were also polyI-polyC injected. 
As our goal was to study the potential eff  ects of Fbw7 dele-
tion on HSC homeostasis, we turned our attention to the 
lineage         compartment. It was immediately obvious that Fbw7 
deletion rapidly (at 2 wk after polyI-polyC) and signifi  cantly 
can deplete the HSC compartment, possibly by promoting their 
diff  erentiation into more mature, lineage-restricted cells (  7  ). 
Also, Stier et al. (  16  ) suggested that Notch pathway activa-
tion increases HSC self-renewal in vivo. On the other hand, 
several genetic studies questioned the importance of Notch1 
signaling at this stage. Initially, deletion of the central Notch 
eff  ector RBP-J (signal binding protein-J) caused no signifi  cant 
HSC or progenitor-specifi  c phenotypes (  17  ). Similarly, no gross 
hematopoietic defects were reported when either the Notch 
ligand Jagged1 or the Notch regulators Numb and Numblike 
were conditionally deleted (  18, 19  ). 
  Although it is clear that the expression of numerous cell 
cycle regulators must be tightly controlled in HSCs to permit 
both their self-renewal and diff  erentiation, the molecular 
pathways that provide such control are mostly unclear. Notch1 
and c-Myc, as well as other cell cycle regulators like cyclin E 
and c-Jun, are targeted for proteasomal degradation by the E3 
ubiquitin ligase, Fbw7 (  20, 21  ). Fbw7 (also called Fbxw7, 
hCDC4, Ago, and SEL-10) is an F-box protein that serves as 
a receptor molecule for the Skp1/Cul1/F-box protein (SCF) 
ubiquitination complex. Fbw7 binds substrates (e.g., Notch1 
and c-Myc) by recognizing a phosphorylated motif (a degron) 
via its WD40 repeat domain (  22  ). Fbw7 is simultaneously 
bound via its F-box domain to the adaptor protein Skp1, 
which in turn is bound to the RING fi  nger protein Rbx1 via 
the scaff  old protein Cul1, which allows recruitment of target 
proteins for poly ubiquitination by an Rbx1-associated ubiq-
uitin-conjugating enzyme (E2) (  23  ); this marks the target pro-
tein for degradation by the 26S proteasome (  24  ). 
  Our laboratory and others have recently shown that inac-
tivating mutations in Fbw7 contribute to the accumulation 
of Notch1 and c-Myc in T cell  –  acute lymphoblastic leuke-
mia (T-ALL) (  25  –  27  ), and several other studies have estab-
lished Fbw7 as an important tumor suppressor in various tissues 
(  28, 29  ). Furthermore, growing evidence suggests that the 
ubiquitin  –  proteasome system plays diverse and essential roles 
in stem cell biology (  30  ). The ability of Fbw7 to antagonize 
cell cycle progression via the ubiquitin  –  proteasome system 
prompted us to study the eff  ects of deleting it from hemato-
poietic cells. As germline Fbw7 knockout mice die in utero 
around day E10.5 due to defects in vascular development 
(  31, 32  ), we have generated a conditional allele to allow tis-
sue-specifi  c inactivation of Fbw7 on expression of Cre re-
combinase. We report here that loss of Fbw7 function leads 
to a severe depletion of the HSC pool and HSC self-renewal 
capacity due to the loss of stem cell quiescence. This func-
tional phenotype coincides with a perturbed expression of 
critical molecular regulators of cell cycle entry in HSCs and a 
profound decrease in the expression of gene transcripts asso-
ciated with the HSC self-renewal phenotype. 
    RESULTS   
  Fbw7 expression patterns during early 
hematopoietic differentiation 
  To study the pattern of Fbw7 expression during early hema-
topoiesis, we have initially purified the HSC-containing JEM VOL. 205, June 9, 2008 
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(  Fig. 2 C  ) was also decreased. Further subdivision of the LSK 
fraction to long-term HSC (LT-HSC), short-term HSC, and 
multipotential progenitors (using a combination of CD34 
and c-kit staining) did not reveal any subset-specifi  c eff  ects but 
suggested a more general eff  ect on LSK homeostasis (  Fig. 2 D  ). 
As a consequence of the HSC defect, absolute numbers of all 
BM-mature lineages, including the numbers of immature 
(B220  +  IgM  +  ) and mature B cells, were also signifi  cantly de-
creased (  Fig. 2 F  ). These fi   ndings strongly suggested that 
Fbw7 deletion could aff  ect LSK cell self-renewal and/or dif-
ferentiation in the BM. 
  Deletion of Fbw7 severely affects progenitor maintenance 
in the thymus 
  As LSKs have been shown to represent the major thymus-
colonizing population, we analyzed the thymus after Fbw7 
deletion and found no signifi  cant change in total thymocyte 
numbers 2 wk after polyI-polyC deletion (  Fig. 3 A  ).   How-
ever, at later time points (4 wk after polyI-polyC) Mx-cre  +   
Fbw7  f/f   thymocyte numbers were signifi  cantly decreased 
(  Fig. 3 A  ). Notch1 appeared to be the main Fbw7 substrate in 
the thymus, as its deletion led to a signifi  cant accumulation 
of intracellular Notch1 protein as detected by two diff  erent 
Notch1-specifi   c antibodies (Fig. S2 A, available at http://
www.jem.org/cgi/content/full/jem.20080277/DC1). This 
fi  nding was consistent with our recent identifi  cation of Notch1 
as a substrate of Fbw7 in T cells. Supporting this observation, 
Deltex1 transcription, a reliable Notch1 reporter, was signifi  -
cantly up-regulated in Mx-cre  +   Fbw7  f/f   thymi (Fig. S2 B). On 
the other hand, other putative Fbw7 substrates like c-Myc or 
cyclin E were not signifi   cantly stabilized in total Mx-cre  +   
Fbw7  f/f   thymocytes at this specifi  c time point (Fig. S2 A). 
  As evident from   Fig. 3 B  , Fbw7 deletion appeared to sig-
nifi  cantly aff  ect the most immature (CD4        8        ) thymocytes as 
both their frequency and their absolute numbers decreased 
two- to sixfold (  Fig. 3, B and C  ). As this CD4        8         double 
negative (DN) population includes the most immature T cell 
progenitors, we have further subdivided this subset using an-
tibodies against CD25, CD44, and c-kit. This analysis re-
vealed an almost complete absence of both DN2 (CD25  +  44  +  ) 
and DN3 CD44        25  +   thymocytes (  Fig. 3, D and E  ). These 
phenotypes depended on the timing of the deletion mediated 
by the Mx1 promoter that is active both in thymocytes and 
their immediate BM progenitors. Indeed, when we deleted 
Fbw7 only in developing thymocytes using the Lck promoter 
(  34  ) (Lck-cre  +  Fbw7  f/f  ), none of these DN cell  –  specifi  c phe-
notypes were obvious (  Fig. 3 F   and Fig. S3 A). This could be 
explained by the later Fbw7 gene deletion in the Lck-cre model 
(Fig. S3 B). 4-wk-old Lck-cre  +  Fbw7  f/f   mice had thymocyte 
numbers similar to Lck-cre  +  Fbw7  wt/wt   control littermates, and 
almost 50% of them developed T cell lymphomas later in life 
(unpublished data and reference   35  ). Both Notch1 and c-Myc 
appeared to be stabilized in the thymi of these mice. Notch1 
was also stabilized in immature CD4        8         thymocytes (not de-
picted). To further investigate the hypothesis that the thymic 
phenotype was at least partially due to the decreased number 
aff  ected LSK frequency. Most importantly, absolute num-
bers of LSK cells decreased three- to fi  vefold (  Fig. 2 B  ). A 
signifi  cant decrease in the numbers of the fi  rst MPs (lineage       
Sca-1        c-Kit  +  ) was also seen, but there were no signifi  cant 
diff  erences in the relative abundance of common, mega-
karyocyte-erythrocyte, and granulocyte-monocyte progeni-
tors (  Fig. 2 E  ). In agreement with these fi  ndings, the LSK 
frequency in the peripheral blood (not depicted) and spleen 
    Figure 1.         Generation of a conditional Fbw7 allele.   (A)  Targeting 
strategy showing exons 4  –  7 of the mouse genomic Fbw7 locus before 
targeting (WT allele) and after homologous recombination in C57BL/6   ×   
129 ES cells (targeted allele), which introduces an FRT- and LoxP-fl  anked 
PGK-Neo cassette between exons 6 and 7, and fl  anks exons 5 and 6 with 
LoxP sites. Germline removal of the PGK-Neo cassette using the FLPe-
deleter strain and subsequent exposure to Cre recombinase results in exci-
sion of exons 5 and 6 and generates the conditional knockout (CKO) allele. 
Arrows show locations of primers (A  –  D) used to genotype resulting mice. 
(B) Before crossing to the FLPe-deleter strain, PCR using primers C and D 
were used to confi  rm transmission of the targeted allele (not depicted). 
After removal of the PGK-Neo cassette, primers B and C were used to 
detect both the   “  fl  oxed  ”   and WT alleles (497 and 315 bp, respectively). 
After induction of Mx-Cre with polyI-polyC injections, the fl  oxed band was 
lost from the BM and thymus, and excision of exons 5 and 6 in these tis-
sues was confi  rmed by PCR using primers A and C, which amplify 662 bp 
from the CKO allele. (C) Loss of WT Fbw7 expression was confi  rmed by 
quantitative RT-PCR using the same primers as in panel A, which are lo-
cated in exons 4 and 5. Error bars show the SD of duplicate wells.     1398 HSC REGULATION BY FBW7 | Thompson et al.
the BM HSC niche), we have tested whether the reported 
phenotypes were cell autonomous. We used a competitive 
transplantation assay mixing Mx-cre  +  Fbw7  f/f   or Mx-cre  + 
Fbw7  wt/wt   CD45.2  +   BM cells (from polyI-polyC  –  injected 
mice) with CD45.1  +   WT cells. At the time of the injec-
tion, we had normalized for absolute numbers of LSK cells 
and injected     10  3   LSK cells from each genotype. These cells 
were transplanted in irradiated CD45.1 hosts, and chimerism 
was studied 5 wk later. We should note here that in this as-
say we expected   <  50% CD45.2 chimerism due to the exis-
tence of endogenous, host-derived CD45.1  +   cells. The exact 
CD45.2 chimerism depended on the injection effi   ciency and 
in our hands varied from 10 to 45%. Indeed, although Mx-
cre  +  Fbw7  wt/wt   cells effi   ciently competed (generating   >  40% 
of entering BM stem and progenitor cells, we have quantifi  ed 
the absolute number of the fi  rst thymic immigrants (early T 
cell progenitors [ETPs], defi  ned  as  lineage        CD25        c-kit  high   
cells) in the thymi of control and mutant mice 2 and 4 wk af-
ter polyI-polyC injection. As shown in   Fig. 3 G  , ETP num-
bers were signifi  cantly decreased upon Fbw7 deletion at both 
time points. Our studies demonstrated that deletion of Fbw7 
using the Mx-cre  +  Fbw7  f/f   model severely aff  ects lymphocyte 
development in the thymus. 
  Loss of Fbw7 leads to a cell-autonomous defect of 
stem cell self-renewal 
  As the Mx1 promoter is IFN-      responsive and can drive cre-
recombinase expression in nonhematopoietic lineages (e.g., 
    Figure 2.         Fbw7 deletion leads to a depletion of BM hematopoietic progenitors.   (A) Absolute numbers of BM cells in polyI-polyC  –  injected control 
(Fbw7  f/f ,  MxCre       ) and CKO (Fbw7  f/f ,  MxCre +  ) mice 2 wk after polyI-polyC deletion are shown. (B) Lin         BM cells were stained for c-kit and Sca-1 to mark the 
LSK population (dot plot), and absolute LSK numbers (histogram) were calculated (also at 2 wk after polyI-polyC). (C) Quantitation of peripheral (spleen) 
LSKs 2 wk after polyI-polyC injection. P   <   0.05. (D and E) Absence of enhanced rates of apoptosis as defi  ned by a combination of 7-AAD/annexin V staining 
in either total BM of LSK cells (3 wk after polyI-polyC injection). (F) LSK cells were analyzed by FACS for CD34 expression to separate long-term (LT, CD34       ) 
from short-term (ST, CD34  +  ) HSCs. (G) MPs (Lin       /Sca-1      /c-kit +  ) were analyzed by FACS for CD34 and Fc     RII/III expression to show common MPs (CMP, 
CD34  + /  Fc   RII/III       ; bottom right gate), granulocyte/macrophage progenitors (GMP, CD34  + /  Fc   RII/III +  ; top right gate), and megakaryocyte/erythroid pro-
genitors (MEP, CD34  lo   /  Fc   RII/III       ; bottom left gate). (H) Absolute number of mature (IgM  + /B220 hi  ) and immature (IgM  + /B220 +  ) BM B cells are shown (2 wk 
after polyI-polyC). Error bars show the SD. Numbers indicate the percentage of cells in each gate. *, P   <   0.05; **, P   <   0.005. For all experiments,   n   =  8.   JEM VOL. 205, June 9, 2008 
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into irradiated CD45.1 hosts and documented chimerism 3 wk 
later. Only after transplant did we inject the recipients with 
polyI-polyC (three times) to delete the Fbw7 locus. 7 wk af-
ter polyI-polyC injection, we found no (or very few) mature 
donor-derived Fbw7       /       cells (thymocytes, B cells, Mac1  +  , 
NK1.1  +  , and Gr-1  +   cells), including BM LSK (Fig. S4, available 
at http://www.jem.org/cgi/content/full/jem.20080277/DC1). 
These combined transplantation results strongly demonstrated 
that the Fbw7 deletion-induced phenotype is cell autonomous 
and is not due to the inability of Fbw7 LSK to home to the 
marrow niche. 
  Deletion of Fbw7 leads to defective HSC quiescence 
and self-renewal 
  To begin understanding the molecular mechanism behind the 
HSC defect caused by the deletion of Fbw7, we initially stud-
ied LSK survival in the BM of polyI-polyC  –  injected animals 
(at 2, 3, and 4 wk after injection). No signifi  cant diff  erences 
in the percentage of apoptotic LSK in polyI-polyC  –  injected 
littermate mice (Mx-cre  +  Fbw7  f/f  , Mx-cre  +  Fbw7  wt/wt  , or Mx-
cre  +  Fbw7  f/w  ) were observed at 3 wk after polyI-polyC (  Fig. 2  ), 
chimerism) with CD45.1 BM, Mx-cre  +  Fbw7  f/f   cells gener-
ated only minimal chimerism in the spleen, thymus, and BM 
of the recipient animals, suggesting a very severe defect in 
their ability to diff  erentiate and replenish the hematopoietic 
and immune systems (  Fig. 4 A  ).   Interestingly, when we stud-
ied chimerism in the LSK compartment we found almost no 
Fbw7       /       LSK cells (  Fig. 4 B  ). Similarly, in the BM,   <  3% of 
total BM mononuclear cells derived from Fbw7       /       progen-
itors. Very few of these cells managed to properly diff  erenti-
ate toward the myeloid (not depicted) or B cell lineage (  Fig. 
4 C  ). Moreover,   <  0.1% of total donor-derived thymocytes 
originated from Fbw7       /       BM. Once more, these cells failed 
to diff  erentiate to the CD4  +  8  +   stage, and the vast majority 
belonged to the early CD44  +  25  +   DN1 stage (  Fig. 4, D and E  ). 
These experiments demonstrated that Fbw7       /       stem cells were 
unable to compete with WT counterparts. 
  As the previous results could also be explained by altered 
the homing ability of HSCs upon Fbw7 deletion, we altered our 
transplantation protocol so that we transplanted 0.5  ×   10  6   non-
polyI-polyC  –  injected (Mx-cre  +  Fbw7  f/f   or Mx-cre  +  Fbw7  wt/wt  ) 
CD45.2  +   BM cells with an equal number of CD45.1  +   WT cells 
    Figure 3.         Loss of Fbw7 severely impairs early T cell development.   (A) Absolute numbers of thymocytes (left, 2 wk after polyI-polyC; right, 4 wk 
after polyI-polyC) were counted from control (  n   = 8) and CKO (  n   = 8) mice and analyzed by FACS for CD4 and CD8 expression (B). (C) Absolute numbers 
of CD4       8        DN cells (2 wk after polyI-polyC). (D) DN cells were separated into DN1  –  4 populations by staining for CD44 and CD25. (E) Absolute numbers 
of DN2 (CD44  + /CD25 +  ) and DN3 (CD44       /CD25 +  ) (2 wk after polyI-polyC). (F) DN thymocytes were analyzed as in D in control (Fbw7  f/f ,  LckCre      )  and  CKO 
(Fbw7  f/f ,  LckCre +  ) mice. Error bars show the SD. Numbers indicate the percentage of cells in each gate. **, P   <   0.005.   n   = 6. (G) Absolute numbers of ETP 
(Lin       CD25      CD44 + c-kit +  ) cells 2 and 4 wk after polyI-polyC injection. *, P   <   0.05.   n   =  4.   1400 HSC REGULATION BY FBW7 | Thompson et al.
  We then asked whether this loss of quiescence translates to 
defective HSC self-renewal or diff  erentiation. We used colony-
forming cell assays and initially plated total BM from polyI-
polyC  –  treated Mx-cre  +  Fbw7  wt/wt   or Mx-cre  +  Fbw7  f/f   animals 
and incubated them in semi-solid methylcellulose medium 
in the presence of a suitable cytokine cocktail. As shown in 
  Fig. 5 C  , Mx-cre  +  Fbw7  f/f   cells generated only half the number 
of colonies compared with Mx-cre  +  Fbw7  wt/wt   progenitors. 
Also, these colonies were signifi  cantly smaller in size (  Fig. 5 E  ). 
We then performed similar experiments using highly enriched 
CD34         LT-HSCs. Interestingly, during the initial plating no 
diff  erences in the absolute numbers of colonies were recorded. 
However, the replating of colonies that originated from Mx-
cre  +  Fbw7  f/f   LT-HSCs showed a complete loss of self-renewal 
capacity (  Fig. 5 D  ) in agreement with our in vivo competitive 
reconstitution assays (  Fig. 4  ). These observations clearly showed 
that Fbw7 deletion promotes aberrant cell cycle entry and loss 
of self-renewal. 
  BM Fbw7 deletion leads to c-Myc protein stabilization 
  As Fbw7 is able to ubiquitinate and degrade several target 
proteins, we performed an initial protein expression screening 
of three well-characterized substrates, Notch1, c-Myc, and 
cyclin E (  Fig. 6  ).   We were unable to detect signifi  cant ex-
pression and stabilization of either Notch1 or cyclin E in total 
BM cells. This result was not surprising, as Notch1 mRNA is 
arguing against the involvement of the SCF  Fbw7   complex in 
LSK survival. 
  To address the eff  ect of Fbw7 deletion on stem cell pro-
liferation, we used Ki67 and DAPI labeling to determine 
the cell cycle status of LSK cells. The percentage of Mx-
cre  +  Fbw7  f/f   LSK cells that passed the G0-G1 checkpoint 
and entered cycle was consistently and signifi  cantly elevated 
when compared with Mx-cre  +  Fbw7  wt/wt   counterparts (  Fig. 5 A  ).   
Interestingly, these eff  ects appear to be LSK specifi  c, as more 
diff  erentiated cell populations (MPs, T cell progenitors, CD4  +  8  +   
thymocytes) do not show similar cell cycle acceleration 
(Fig. S5, available at http://www.jem.org/cgi/content/full/
jem.20080277/DC1). To further support these fi  ndings, we 
have used a short (42-h) pulse of BrdU to mark cells that 
escape quiescence and enter the cell cycle, and subdivided 
the LSK compartment into CD34         (self-renewing LT-HSC) 
and CD34  +   (non-self  –  renewing short-term  –  HSC and MPP) 
subsets. As evident from   Fig. 5 B  , Fbw7       /       LT-HSCs showed 
a dramatic loss of quiescence, as almost 80% of them en-
tered cell cycle during the 42 h from the initiation of the 
BrdU pulse. CD34  +   LSK cells also showed a signifi  cantly 
elevated fraction of BrdU  +   cells. We should also note here 
that LSK cycle deregulation was evident even in marrows with 
less signifi  cant alterations in LSK or total cell numbers, suggest-
ing that the functional changes preceded the phenotypic ones 
(not depicted). 
    Figure 4.         Loss of Fbw7 leads to a cell-autonomous defect of HSC self-renewal.   (A) 0.5   ×   10  6   WT CD45.1 BM cells were injected into lethally ir-
radiated WT Ly 5.1  +   host mice (  n   = 3 for each experiment) with the same number of either control CD45.2 or CKO (Mx1-cre  + Fbw7 f/f  ) CD45.2 BM cells. 
The mice were analyzed 5 wk later for reconstitution of the BM, thymus, and spleen by staining cells from each tissue for both CD45.1 and CD45.2. 
The percent contribution of each donor to those organs is shown. CD45.2-gated cells from recipient mice were analyzed by FACS for expression of CD4, 
CD8, CD44, and CD25 in the thymus (D and E), B220/IgM (C), and LSK markers (B) in the BM. The cells in E are gated on the thymic Lin         population. 
Numbers indicate the percentage of cells in each gate.     JEM VOL. 205, June 9, 2008 
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cells from polyI-polyC  –  injected Mx-cre  +  Fbw7  f/f   mice (and 
Mx-cre  +  Fbw7  wt/wt   controls). We placed these cells in a liquid 
culture in the presence of cytokines as shown in   Fig. 7  .   Once 
more, we have detected no stabilization of either Notch1 
or cyclin E (not depicted). On the other hand, c-Myc pro-
tein was substantially overexpressed (almost threefold). Also, 
the accumulated c-Myc protein was phosphorylated on the 
T58 and S62 residues, in agreement with the idea that phos-
pho species of the c-Myc substrate should accumulate in 
the absence of proteasomal degradation (  Fig. 6 B  ). Further 
quantitative RT-PCR experiments have proven that the 
c-Myc stabilization was due to posttranslational modifi  cation 
(  Fig. 6 C  ). This c-Myc stabilization was persistent between 
diff  erent experiments. These results (  Fig. 6 C  ) suggested that 
Fbw7 deletion in stem cell and progenitor populations led to 
a signifi  cant stabilization of c-Myc but not Notch1 or cyclin 
E proteins. 
  Dynamic regulation of Fbw7 expression during HSC cycle 
entry and differentiation 
  Previously presented results suggest that Fbw7 is an HSC 
cycle entry   “  brake  ”   and that its deletion aff  ects HSC quies-
cence. In agreement with this scenario, Fbw7 expression is 
signifi  cantly down-regulated as LSKs diff  erentiate to   become 
not expressed in mature myeloid/erythroid/B cells that com-
prise the vast majority of the marrow. Also, cyclin E is ex-
pressed in a small fraction of actively cycling progenitors (  36  ). 
Similarly, c-Myc expression was diffi   cult to detect (  Fig. 6 A  ). 
Once more, this was an anticipated fi  nding, as c-Myc is only 
expressed in a small fraction of BM cells (unpublished data). 
  These observations suggested that we should focus our 
attention on the small fraction of BM cells that includes puta-
tive stem cells and progenitors. We have thus sorted LSK 
    Figure 5.         Deletion of Fbw7 leads to defective HSC quiescence and 
self-renewal.   (A) LSK control and Mx1-cre  + Fbw7 f/f   (CKO) mice were fur-
ther analyzed for DNA content (DAPI) and intracellular Ki-67 expression 
(2 wk after polyI-polyC). Quadrants correspond to cell cycle stages as shown 
in the left panel. The percentage of LSK cells in G0 stage is also shown 
(  n   = 6), (B) BrdU labeling of the CD34         and  CD34 +   LSK subsets (  n   =  4) 
(2 wk after polyI-polyC). (C) 25,000 total BM cells from control or CKO mice 
were plated in methylcelluose medium containing a multilineage cytokine 
cocktail. The number of colonies and their qualitative morphologies were 
determined 8 d later. (D) The same experiment as in C was performed, 
except plating 500 fl  ow-purifi  ed LT-HSCs per plate. After 7 d, the colonies 
were counted (fi  rst plating). The colonies from each plate were pooled 
and resuspended in PBS, and 2,000 of those cells were replated for an 
additional 7 d before counting colonies again (second plating). Numbers 
indicate the percentage of cells in each gate. (E) Photographs of repre-
sentative colonies from C (fi  rst plating) show the relative size difference 
between control- and CKO-derived colonies. Bar, 0.5 mm. These are 
representatives of at least three individual experiments. *, P   <   0.05; 
**,  P   <   0.005.   
    Figure 6.         Effects of Fbw7 deletion on target protein stabilization 
in the BM.   (A) Western blot detecting expression of Notch1-IC, un-
cleaved membrane Notch1 (Notch1-TM), c-Myc, cyclin E, and b-actin in 
total BM extracts. (B) Expression of c-Myc in cytokine-stimulated BM 
progenitors. Lineage       IL-7R         Sca-1 high c-kit high   cells from control and CKO 
(Mx-cre  + Fbw7 fl  ox/fl  ox  ) mice were cultured for 48 h in the presence of cyto-
kines. c-Myc expression was quantifi  ed using densitometry and actin 
normalization. Phospho  –  c-Myc (T58/S62) and actin levels are also shown. 
A representative of three experiments is shown. (C) Quantitative RT-PCR 
quantifying expression of Fbw7 and c-Myc in the cells used in B. Ex-
pression is normalized using b-actin.     1402 HSC REGULATION BY FBW7 | Thompson et al.
  Fbw7 controls a gene program that correlates with HSC 
quiescence and self-renewal 
  To further characterize the molecular mechanism of Fbw7 
function in the diff  erentiation and homeostasis of HSCs, we 
have performed a whole transcriptome analysis. We have used 
FACS-purifi  ed lineage        IL7R             c-kit  high  Sca-1  high   stem/multi-
lineage progenitors (LSK) and lineage        IL7R             c-kit  high  Sca-1         
MPs from polyI-polyC  –  injected pooled Mx-cre  +  Fbw7  f/f   and 
Mx-cre  +  Fbw7  wt/wt   littermate mice, extracted total RNA, and 
used it for microarray analysis. Both the array analysis (not 
depicted) and quantitative RT-PCR (  Fig. 8 A  ) showed that 
deletion of the Fbw7 locus and silencing of its expression in 
the LSK and MP compartments used for these experiments 
were complete.   
  We have performed an analysis of genes that showed a 
greater than or equal to threefold diff  erence in expression be-
tween the control and Fbw7       /       LSK cells. This analysis dem-
onstrated that Fbw7       /       LSK cells were more closely related 
to the diff  erentiated MP populations than the control LSK 
subset (not depicted). The combination of published studies 
(  37  –  40  ) and our own results (Table S1, available at http://
www.jem.org/cgi/content/full/jem.20080277/DC1, and 
unpublished data) suggested a partial transcriptional   “  signa-
ture  ”   associated with the LT-HSC phenotype. These tran-
scripts are enriched in LT-HSCs and down-regulated upon 
the loss of self-renewal properties. We thus hypothesized 
that the transcriptional signature of Fbw7 deletion in HSCs 
contains the features of the physiological loss of stem cell phe-
notype associated with the commitment to the transiently 
amplifying progenitor fate. Such a hypothesis was supported 
by the identities of genes specifi  cally aff  ected by Fbw7 dele-
tion in the LSK compartment (not depicted), including   Evi1  ,   
Mpl  ,   p57  ,   Agpt  ,   Eya1/2  ,   Pbx3  , and   Meis1  , which were all 
previously shown to be enriched in self-renewing HSCs 
(Table S1). These results were further verifi  ed using quantitative 
RT-PCR analysis of distinct biological samples (  Fig. 8 B  ) and 
were perfectly in line with the presented phenotypic results, 
which suggested a loss of HSC quiescence and self-renewal 
capacity upon Fbw7 deletion. Importantly, the observed global 
loss of HSC-specifi  c transcriptional signature was not an artifact 
from contaminating Sca-1  low/       cells, as the Ly6A (Sca-1)  –  spe-
cifi  c signal was even slightly higher in the Fbw7       /       compared 
with the control LSK sample (not depicted). 
  This loss of   “  LT-HSC  –  specifi  c  ”   gene expression was ac-
companied by the activation of a more diff  erentiated gene 
expression program in cells that lose Fbw7 expression. In-
deed, several genes suggesting an erythro-myeloid and lym-
phoid priming (  38  ) were up-regulated upon Fbw7 loss (i.e., 
glycophorin A, CD36, neutrophil elastase, Rag-1, etc.; not 
depicted). This is consistent with the presented expression 
analysis data that show that Fbw7 mRNA expression decreases 
during the transition of undiff  erentiated LSK cells to the 
committed progenitor stage, which could be a functional part 
of the early HSC diff  erentiation program. 
  Finally, we have searched for genes that could explain the 
loss of stem cell quiescence upon Fbw7 deletion. As shown in 
MPs (Fig. S1). To further understand the role of Fbw7 dur-
ing physiological HSC proliferation and diff  erentiation, we 
purifi  ed LSK cells and placed them in cytokine-driven in 
vitro cultures. Before the cytokine stimulation (day 0), al-
most 60% of the cells were in G0. Upon stimulation, cells 
rapidly entered cycle with only 2  –  3% of cells in G0 at day 2 
(  Fig. 7 A  ). Fbw7 expression declined signifi  cantly in response 
to cytokine stimulation, and Cul1 expression followed an 
identical pattern (  Fig. 7 B  ). Although these results suggested 
that Fbw7 expression is dynamically regulated at the HSC 
stage, it is diffi   cult to uncouple proliferation from diff  eren-
tiation-triggered eff  ects. We further quantifi  ed cell diff  eren-
tiation by measuring the proportion of cells that lost Sca-1 
expression. As shown in   Fig. 7 C  , at day 1 almost 80% of the 
cells retained their c-kit  +  Sca-1  +   phenotype, whereas Fbw7 
expression was decreased three- to fourfold. Although eff  ects 
of diff  erentiation are not excluded, this observation suggested 
that Fbw7 message expression is down-regulated as HSCs 
enter cell cycle. 
    Figure 7.         Dynamic regulation of Fbw7 expression during HSC cycle 
entry and differentiation.   (A)  Flow-purifi  ed LSK cells were cultured with 
cytokines for 0, 1, or 2 d and were stained for intracellular Ki-67 and DNA 
content (DAPI). (B) Fbw7 and Cul1 mRNA expression were analyzed by 
quantitative RT-PCR on each day. (C) Quantifi  cation of Sca-1 expression 
(loss of Sca-1 indicates differentiation of LSK cells) after each day of cul-
ture. On day 0, all cells are Sca-1  + .   JEM VOL. 205, June 9, 2008 
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been previously suggested to be targets of c-Myc, supporting 
our view that c-Myc overexpression could be an important 
regulator of cell cycle entry downstream of Fbw7 (  41  –  43  ). 
The presented expression studies provide a very strong mecha-
nistic basis that explains the phenotypic and functional eff  ects 
of Fbw7 deletion on HSC quiescence and self-renewal. 
    DISCUSSION   
  In this report we demonstrate that a single E3 ubiquitin li-
gase, Fbw7, is an essential regulator of HSC quiescence and 
  Fig. 8 C  , several cell cycle regulators, including p27, p21, and 
Ccnd2/3, were unaff  ected by the deletion of Fbw7. However, 
the expression of three cell cycle  –  related genes was altered in 
response to Fbw7 silencing. The cyclin kinase inhibitor p57  kip2  , 
previously implicated in loss of quiescence of stem cells (  38  ), 
was down-regulated in Mx-cre  +  Fbw7  f/f   LSK cells. On the 
other hand, the cell cycle regulator E2F2 was signifi  cantly up-
regulated upon Fbw7 loss. Finally, the D-type cyclin Ccnd1 
was up-regulated after Fbw7 gene excision, in agreement with 
its role in HSC cycle entry. Interestingly, all three genes have 
    Figure 8.         Fbw7 controls genes that correlate with HSC quiescence and self-renewal.   (A)  Effi  cient silencing of Fbw7 expression in LSK cells and 
MPs in response to polyI-polyC treatment (at 2 wk after treatment). (B) Quantitative RT-PCR validation of genes selected from the microarray using 
mRNA from a different sorting experiment. The plotted expression values represent the relative mRNA level of each sample normalized to the median 
expression across all samples. (C) Quantitative RT-PCR analysis of the expression of multiple cell cycle  –  related genes in control (Mx-cre  + Fbw7 +/+  ) and CKO 
(Mx-cre  + Fbw7 fl  /fl   )  LSK  cells.   1404 HSC REGULATION BY FBW7 | Thompson et al.
ligases on HSC function is scarce and indirect. Studies using 
a panel of chemical proteasome inhibitors have shown that 
suppression of proteasome function induced cell death in 
human CD34  +   hematopoietic progenitors (  48  ). Moreover, 
primary CD34  +   leukemic stem cells also enter apoptosis in 
response to treatment with the MG-132 proteasome inhibi-
tor (  49  ). However, these were crude experiments that cannot 
address the complexity of regulation of proteasome function 
in HSCs by the diff  erent ubiquitin ligase complexes. Experi-
ments similar to the ones described in this report, which 
include E3 ligase expression mapping and gene-targeting ex-
periments, are thus essential for the detailed understanding of 
the importance of ubiquitination in HSC function. 
  Multiple protein substrates of Fbw7 have been identifi  ed. 
These include the cell cycle regulator cyclin E and transcrip-
tion factors such as c-Myc and Notch (  50  ) that could directly 
or indirectly regulate stem cell function. Our protein expres-
sion analyses showed no stabilization of Notch1 in the BM of 
Mx-cre  +  Fbw7  f/f   mice. In fact, we were unable to detect any 
Notch1-IC protein expression at all. This was not due to any 
technical obstacle, as Notch1 was signifi  cantly stabilized and 
overexpressed in the thymus of these mice. Also, we were 
unable to detect CD4  +  8  +   cells in the Fbw7       /       BM (not 
depicted), usually a reliable and rapid indicator of aberrant 
Notch activation (  51, 52  ). However, we cannot exclude that 
Notch stabilization occurs in a small fraction of LSK cells, and 
this change in protein expression is below the sensitivity of 
the experimental method used. Indeed, Matsuoka et al. (  44  ) 
detected Notch1 overexpression using confocal microscopy 
of individual Fbw7       /       LSK cells. In agreement with these 
results, our RT-PCR analysis of Fbw7       /       LSK cells has re-
vealed a persistent overexpression of Hes-1 and Deltex-1, both 
well-characterized targets of the Notch pathway (  Fig. 8 C  ). 
  Similar studies excluded a role for stabilization of another 
Fbw7 substrate, cyclin E. Indeed, we were unable to detect 
any signifi  cant cyclin E stabilization in response to Fbw7 
deletion in either total BM cells or purifi  ed stem cell and 
progenitor populations. These fi  ndings are consistent with 
genetic experiments reported by Loeb et al. (  51  ). These in-
vestigators have generated   “  knock-in  ”   mice that express a 
mutated cyclin E, cyclin E  T393A  . T393 falls within a canonical 
Fbw7 recognition degron, and its phosphorylation allows 
Fbw7 to bind and ubiquitinate cyclin E. Mutated cyclin E 
was stabilized and expressed at levels several-fold higher in 
several tissues, including lymphocytes and thymocytes. De-
spite this overexpression, cyclin E  T393A    –  homozygous mice 
showed no phenotypic abnormalities in all tissues examined, 
including the immune system. They also displayed a normal 
life span with no signifi  cant predisposition to autoimmune 
disease or tumor induction. Together with our protein ex-
pression analyses, these elegant genetic studies argue against a 
role of cyclin E stabilization in HSC function in response to 
Fbw7 deletion. 
  On the other hand, our studies suggested that c-Myc 
could be an attractive target, especially because it was pre-
viously shown to be involved in HSC diff  erentiation (  11  ). 
self-renewal. Fbw7 is expressed in quiescent HSCs, and its 
expression is down-regulated upon the loss of their self-
renewing capacity. These eff  ects are cell autonomous, as 
Fbw7       /       LSKs are unable to compete with WT counterparts 
both in vitro and in vivo. The loss of LSK absolute numbers 
and self-renewal abilities are also refl  ected at the early stages 
of lymphopoiesis, as Mx-cre  +  Fbw7  f/f   mice have lower num-
bers of B cell, and almost no T cell, progenitors. To mecha-
nistically explain these LSK phenotypes, we have performed 
comparative gene expression studies using Fbw7       /       stem 
cells and MPs. These studies demonstrated that Fbw7 dele-
tion targets specifi  c cell cycle regulators and suppresses the ex-
pression of several genes previously suggested to control HSC 
function. Thus, we have identifi  ed a novel function for the 
proteasome  –  ubiquitin ligase complex as a genetic   “  switch  ”   
that controls HSC cycle entry and self-renewal. 
  Our studies are in agreement with a recent report by 
Matsuoka et al. (  44  ). These investigators also demonstrate 
that Fbw7 is essential to maintain HSC quiescence and self-
renewal, and suggest that c-Myc is a key Fbw7 substrate in 
HSCs. They also report that Fbw7       /       animals die by either 
extreme pancytopenia at 12 wk after polyI-polyC injection 
or by T-ALL. Development of T-ALL was a later event, 
as disease appeared only after 16 wk after treatment. Only 
very few (  n   = 2) of our polyI-polyC  –  injected Fbw7  f/f   ani-
mals were allowed to reach these time points, and all devel-
oped pancytopenia. Thus, we cannot directly compare rates 
of T-ALL induction, as all other polyI-polyC  –  injected ani-
mals presented in this study were analyzed at very early time 
points. However, both Fbw7-targeted animals developed T-
ALL with similar kinetics when crossed to the Lck-cre strain 
(unpublished data and reference   35  ). A discrepancy between 
the two studies exists over the detection of apoptosis in 
Fbw7       /       LSK cells. However, Matsuoka et al. (  44  ) reported 
elevated percentages of apoptosis only in HSCs purifi  ed 
from the marrows of severely cytopenic mice 12 wk after 
deletion. In the studies presented here, the analysis was per-
formed using LSK cells purifi  ed from noncytopenic Fbw7       /       
mice 3 wk after polyI-polyC deletion. At that time point 
there was a signifi  cant alteration of HSC quiescence and a 
reduction of LSK (and LT-HSC) absolute cell numbers. In 
agreement with our fi  ndings, Matsuoka et al. (  44  ) failed to 
detect an increased frequency of apoptosis in HSCs puri-
fi  ed from the BM of noncytopenic animals, even at 12 wk 
after deletion. 
  There are few other examples of stem cell function or 
diff  erentiation being regulated by specifi  c E3 ubiquitin ligases 
(  30  ). Initially, the UBR1/2 E3 ligases were shown to be es-
sential for neurogenesis due to their eff  ects on the diff  erentia-
tion and survival of neural stem cells and progenitors (  45  ). 
Also, in the neural system, the Mindbomb1 ligase regulates 
expression of Notch ligands and consequently controls dif-
ferentiation of neural stem cells (  46  ). Finally, DDB1, an E3 
ligase member of the cullin4A complex, is important for the 
viability, genomic integrity, and maintenance of neural stem 
cells (  47  ). Information on the role of any of the multiple E3 JEM VOL. 205, June 9, 2008 
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clone using homologous recombination. The region was designed such that 
the short homology arm extends 2.4 kb 5      to loxP/FTR-fl  anked NEO cas-
sette. The long homology arm ends on the 3      side of the loxP/FRT NEO 
cassette and was     8-kb long. A single lox P site was inserted upstream of 
exon 5. The target region was 2.1 kb and included exons 5 and 6. The back-
bone vector was     2.1 kb and contained an ampicillin selection cassette. The 
total size of the targeting construct (including the vector backbone) was 
    16 kb. The targeting vector was linearized using NotI and electroporated 
into 129 Sv/En   ×   C57BL6 hybrid ES cells. After G418 selection, surviving 
clones were expanded for PCR analysis to identify recombinant ES cell 
clones. Oligos for ES cell screening and PCR conditions are available upon 
request. Five correctly targeted ES cell clones were expanded for microin-
jection into blastocysts. Strong chimeras were identifi   ed and crossed to 
C57BL6 females to verify germline transmission. The F1 generation was 
PCR screened and crossed to FLP recombinase  –  expressing mice (Jax mice) 
to delete the Frt-fl  anked Neo Cassette. Fbw7  fl  ox/Neo       mice were conse-
quently crossed to Mx1-cre and Lck-cre mice. 
  For our polyI-polyC experiments, we injected 20   μ  g polyI-polyC per 
gram of body weight. We initiated injections 2 wk after birth. Mice were 
injected once every other day for a total of three injections. They were ana-
lyzed 1, 2, and 4 wk after injection. All animal experiments were approved 
by the IACUC of the NYU School of Medicine. 
  Transplantation assays.     For the experiment shown in   Fig. 4  , we have 
mixed BM from either CD45.2 Mx-cre  +  Fbw7  wt/wt   or CD45.2 Mx-cre  +  Fbw7  f/f   
mice (2 wk after the end of polyI-polyC treatment) with WT CD45.1 cells. 
We normalized for absolute numbers of LSK cells in each marrow such that 
we injected 1,000 LSK cells from each genotype. The cells were injected in 
lethally (900 rad) irradiated CD45.1 congenic H57BL6 recipients. We ana-
lyzed chimerism 5 wk after transplant. 
  For the experiment shown in Fig. S4, we mixed (50:50) nonpolyI-
polyC  –  injected whole BM cells (CD45.2 Mx-cre  +  Fbw7  wt/wt   or CD45.2 
Mx-cre  +  Fbw7  f/f   with WT CD45.1 cells). After we verifi  ed chimerism from 
both CD45.1/2 donors (using peripheral blood FACS analysis), we began 
polyI-polyC injections (three). Chimerism was studied 7 wk after the end of 
the polyI-polyC treatment. 
  Genotyping and genomic PCR.     Mouse tails were clipped at 1  –  2 wk 
of age and incubated in tail lysis buff  er for 12  –  24 h at 55  °  C. 6M NaCl was 
added, insoluble debris was pelleted, and DNA was precipitated with iso-
propanol. The resulting DNA pellets were washed with 70% ethanol and 
dissolved in water for PCR analysis. Genomic DNA from BM and thymo-
cytes was prepared by lysing the cells in a solution containing 0.03% NP-40, 
0.03% Tween 20, and 7   μ  g/ml proteinase K for 30 min at 55  °  C, followed 
by 10 min at 100  °  C. This solution was used directly for PCR. Primers were 
designed to selectively amplify WT, targeted (Neo+), targeted (Neo     ), and 
CKO Fbw7 alleles as shown in   Fig. 2  . The sequences are as follows: A F, 
5     -GGCTTAGCATATCAGCTATGG; B F, 5     -ATTGATACAAACTG-
GAGACGAGG; C R, 5     -ATAGTAATCCTCCTGCCTTGGC; and D 
F, 5     -TGCGAGGCCAGAGGCCACTTGTGTAGC. MxCre and LckCre 
transgenes were detected using the following primers: Cre F, 5     -  GCG-
GTCTGGCAGTAAAAACTATC;   Cre R, 5     -  AAGTGACAGCAAT-
GCTGTTTCAC;   and LckF, 5     -  GGTTTGCCCATCCCAGGTG  . All 
PCRs used a T  m   = 58  °  C for 35 cycles, except for Cre PCRs, which used 
a T  m   = 52  °  C. 
  Antibodies and FACS analysis.     Antibody staining and FACS analysis was 
performed as described previously (  11  ). All antibodies were purchased from 
BD Biosciences or eBioscience. We used the following antibodies: c-kit 
(2B8), Sca-1 (D7), Mac-1 (M1/70), Gr-1 (RB6-8C5), NK1.1 (PK136), 
TER-119, CD3 (145-2C11), CD19 (1D3), IL7R      (A7R34), CD34 
(RAM34), Fc     II/III (2.4G2), Flk-2/Flt-3 (A2F10.1), CD4 (RM4-5), CD4 
(H129.19), CD8 (53  –  6.7), CD25 (PC61), and CD44 (IM7). BM lineage 
antibody cocktail includes the following: Mac-1, Gr-1, NK1.1, TER-119, 
CD3, TCR-     , TCR-          , and CD19. 
Indeed, both total and phosphorylated c-Myc protein was 
consistently up-regulated in Fbw7       /       BM stem cells and 
progenitors. These observations were consistent with the 
confocal microscopy studies reported by Matsuoka et al. (  44  ), 
strongly suggesting that c-Myc is indeed an important Fbw7 
substrate. Putative targets of c-Myc, including p57  kip2  , E2F2, 
and Ccnd1, were also up-regulated in Fbw7       /       LSK cells. In 
agreement with this hypothesis, Wilson et al. (  11  ) have per-
formed experiments in which they have overexpressed c-
Myc specifi  cally in LSK cells. Despite proper homing and 
inhibition of apoptosis, c-Myc  –  overexpressing HSCs failed 
to self-renew, a phenotype similar to the one reported here 
(  11  ). We should add here that although c-Myc appears to 
represent an important Fbw7 target, it is possible that there 
are other yet-unidentifi  ed Fbw7 substrates that are important 
for the hematopoietic phenotypes reported here. 
  Our presented studies identify Fbw7 as a novel essential 
regulator of HSC quiescence and self-renewal. Initially, dele-
tion of Fbw7, which was normally expressed at high levels in 
noncycling HSCs, aff  ects the expression of key regulators of 
cell cycle entry, including the D-type cyclin Ccnd1, the cell 
cycle inhibitor p57  kip2  , and the downstream transcriptional 
eff  ector E2F2. The combined action of these regulators could 
induce exit from quiescence and cell cycle entry, as the BrdU 
incorporation experiments convincingly demonstrated that 
upon Fbw7 deletion   >  80% of LT-HSCs have entered cell 
cycle. It is tempting to hypothesize that aberrant cell cycle 
entry forces Fbw7       /       HSCs to exit the quiescent niche and 
lose their self-renewing ability. Once more, our expression 
studies provide mechanistic support to this hypothesis. Fbw7 
deletion dramatically suppresses the expression of several 
genes (  Mpl  ,   Pbx3  ,   p57  ,   Meis1  ,   Evi1  ,   Eya1/2  ,   Angpt  ,   Thy1  , 
and   Ndn  ) that defi  ne a partial   “  LT-HSC  ”   transcriptional sig-
nature (Table S1 and unpublished data). 
  The identifi  cation of Fbw7 as a key regulator of HSC 
quiescence and self-renewal may have very signifi  cant bio-
logical repercussions. Initially, Fbw7 function could be im-
portant for self-renewal of cancer stem cells with important 
implications in the therapeutic targeting of their maintenance. 
In agreement with this notion, Fbw7 deletion suppresses the 
expression of several genes involved in hematopoietic trans-
formation (  Ccnd1  ,   Evi1  ,   Pbx3  , and   Meis1  ). It is intriguing to 
mention here that Fbw7 can also function as a tumor sup-
pressor when deleted in T cells using the Lck-cre  +  Fbw7  f/f   
model (reference   35   and unpublished data), suggesting that 
Fbw7 function in oncogenesis could diff  er between uncom-
mitted stem cells, committed progenitors, and mature lym-
phocytes. For all these reasons, the identifi  cation of regulators 
of Fbw7 activity, including specifi  c deubiquitinating enzymes 
or substrate-specifi  c priming kinases, could be valuable for 
both the development of HSC transplantation protocols and 
the suppression of transformation. 
  MATERIALS AND METHODS 
  Generation of the Fbw7  fl  ox   mice.     An     11.5-kb region used to generate 
the targeting vector was subcloned from a positively identifi  ed C57B6 BAC 1406 HSC REGULATION BY FBW7 | Thompson et al.
  In vitro LSK culture.     LSK cells were sorted from 4  –  8-wk-old C57/B6 
mice and plated in 96-well plates (5,000 LSK per well) in OPTI-MEM sup-
plemented with 10% fetal bovine serum, 50 ng/ml Flt3 ligand, 50 ng/ml 
SCF, 10 ng/ml IL-6, and 10 ng/ml IL-3 (  53  ). Cells were harvested at diff  er-
ent time points for cell cycle analysis and quantitative PCR. For cell cycle 
analysis, cells were fi  xed and permeabilized according to the manufacturer  ’  s 
instructions (Fix and Perm; Invitrogen) and stained with PE-conjugated 
anti  –  Ki-67 (BD Biosciences) or control anti-IgG antibody. Cells were then 
resuspended in PBS containing 5   μ  g/ml RNaseA and 2   μ  g/ml DAPI, and 
analyzed by fl  ow cytometry. 
  Statistical analysis.     The means of each dataset were analyzed using the Stu-
dent  ’  s   t   test, with a two-tailed distribution and assuming equal sample variance. 
Data were considered statistically signifi  cant when P   <   0.05. Signifi  cant data 
are noted in the manuscript as follows: *, P   <   0.05; **, P   <   0.005. 
  Online supplemental material.     Fig. S1 shows Fbw7 expression in diff  er-
ent blood subsets. Fig. S2 shows stabilization of Notch1 in the thymus. 
Fig. S3 shows the phenotype of Lck-Cre  + Fbw7  f/f  thymi. Fig. S4 demon-
strates that the Fbw7       /      phenotype is cell autonomous. Fig. S5 shows that 
the cell cycle defect is specifi  c to HSC. The online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20080277/DC1. 
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